COVID-19 in New Jersey

The Future of Commercial Real Estate in a COVID-19 World

There’s no doubt that COVID-19 will affect the future of commercial real estate in New Jersey, but the question is to what degree? For many of us, the days of commuting into midtown Manhattan or to a New Jersey suburban office park for work seem like a lifetime ago, but what does the digitalization of the workforce mean for companies …

COVID-19 Forcing Developers in New Brunswick, Elsewhere to Rethink Collaborative Spaces

NEW BRUNSWICK, NJ — The COVID-19 pandemic is reshaping the future of collaborative spaces, such as the massive one planned for downtown New Brunswick, the president of DEVCO said Tuesday. Chris Paladino said the virus that has resulted in almost 14,000 confirmed deaths in the Garden State will likely impact the design of projects such as The Hub, a mixed-use …

RUCDR Infinite Biologics to Provide 30,000 Rapid Response COVID-19 Tests Per Day

At what was his 100th COVID-19 press briefing, Gov. Phil Murphy today announced that RUCDR Infinite Biologics, a unit of Rutgers’ Human Genetics Institute of New Jersey, will provide 30,000 rapid-response saliva-based coronavirus tests per day. “Having these tests means we now have 30,000 tests a day that come with a 48-hour turnaround. As test turnaround has lagged nationally given …

NJEDA Has Assisted More than 10K Small Businesses Impacted by COVID-19

The New Jersey Economic Development Authority (NJEDA) today announced that the Authority’s COVID-19 response efforts have supported more than 10,000 businesses since March 2020. In total, the Authority has provided more than $44.2 million in support to 10,624 businesses through grants, low-cost loans, and partnerships with investors and Community Development Financial Institutions (CDFIs). “These programs have provided a vital lifeline …

BioAegis Therapeutics to Proceed with Phase 2 Trial of Gelsolin COVID-19 Treatment

North Brunswick-based BioAegis Therapeutics Inc., has received regulatory clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized patients with severe COVID-19 pneumonia. BioAegis expects to recruit its first patient and begin the study shortly at Hospital Universitari Sant Joan …

Economic Endurance

The New Jersey Economic Development Authority on July 14 unveiled the first two recipients for the expanded version of Angel Investor Tax Credits, which helps investors recoup some of the financial losses incurred from investments in budding technology and life-sciences startups. Under the $25 million program, investors can sell tax credits for up to 20 percent of investments into certain …

Hackensack Meridian CDI, Merck to Collaborate on COVID-19 Research

The collaborative work aims to find drugs to treat the pandemic The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19. The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic. “The CDI was started less than a year ago to provide dynamic research …

BD Launches Portable Antigen Test to Detect SARS-CoV-2 in 15 Minutes

BD (Becton, Dickinson and Company), a Franklin Lakes-based global medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The launch of this new assay that delivers results in 15 minutes on an easy-to-use, highly portable …

N.J. hopes to capitalize on international firms’ sudden need for U.S. production facilities

U.S. companies — and consumers — were not the only ones who suffered when the supply chain of pharmaceuticals, medical devices and supplies, and personal protection equipment got wrecked by the COVID-19 pandemic. International companies did, too. When nations across the world — including many in Europe and Asia — limited essential exports of products to ensure they would have …

WHAT CAN CHOOSE New Jersey DO FOR YOU

Relocation & Expansion Services

We provide customized RFI responses, demographics, detailed market assessments and other complimentary business relocation and expansion services. When your company chooses to grow in New Jersey, we also will help you publicize your good news.

Site Visits

We’ll make your property search seamless, so you find the site that best meets your relocation or expansion needs.

Economic Development Connections

Our public and private partners provide a wide range of services. From higher education research collaboration to regulatory and legal assistance to workforce training, they’ll ensure you have a smooth landing.

Carly Wronko
Marketing Manager
Tiffany Hess-Bennette
Creative Content Specialist